계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Surface Logix
company
About
Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.
- 11 - 50
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $15M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$91.90M
Surface Logix has raised a total of
$91.90M
in funding over 2 rounds. Their latest funding was raised on
Mar 9, 2009 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 9, 2009 | Series E | $15M | 1 | — | — | Detail |
| Mar 24, 2007 | Series D | $19.90M | 1 | — | — | Detail |
| Oct 28, 2005 | Series Unknown | $32M | 1 | — | — | Detail |
| Nov 27, 2002 | Series C | $25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Surface Logix is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
